These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 31522241)

  • 1. Fatty acid amide hydrolase inhibition normalises bladder function and reduces pain through normalising the anandamide/palmitoylethanolamine ratio in the inflamed bladder of rats.
    Charrua A; Matos R; Oliveira R; Marczylo T; Nagy I; Cruz F
    Naunyn Schmiedebergs Arch Pharmacol; 2020 Feb; 393(2):263-272. PubMed ID: 31522241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Full inhibition of spinal FAAH leads to TRPV1-mediated analgesic effects in neuropathic rats and possible lipoxygenase-mediated remodeling of anandamide metabolism.
    Starowicz K; Makuch W; Korostynski M; Malek N; Slezak M; Zychowska M; Petrosino S; De Petrocellis L; Cristino L; Przewlocka B; Di Marzo V
    PLoS One; 2013; 8(4):e60040. PubMed ID: 23573230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological characterization of the peripheral FAAH inhibitor URB937 in female rodents: interaction with the Abcg2 transporter in the blood-placenta barrier.
    Moreno-Sanz G; Sasso O; Guijarro A; Oluyemi O; Bertorelli R; Reggiani A; Piomelli D
    Br J Pharmacol; 2012 Dec; 167(8):1620-8. PubMed ID: 22774772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anandamide-evoked activation of vanilloid receptor 1 contributes to the development of bladder hyperreflexia and nociceptive transmission to spinal dorsal horn neurons in cystitis.
    Dinis P; Charrua A; Avelino A; Yaqoob M; Bevan S; Nagy I; Cruz F
    J Neurosci; 2004 Dec; 24(50):11253-63. PubMed ID: 15601931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. URB937, a peripherally restricted inhibitor for fatty acid amide hydrolase, reduces prostaglandin E2 -induced bladder overactivity and hyperactivity of bladder mechano-afferent nerve fibres in rats.
    Aizawa N; Gandaglia G; Hedlund P; Fujimura T; Fukuhara H; Montorsi F; Homma Y; Igawa Y
    BJU Int; 2016 May; 117(5):821-8. PubMed ID: 26189783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anandamide suppresses pain initiation through a peripheral endocannabinoid mechanism.
    Clapper JR; Moreno-Sanz G; Russo R; Guijarro A; Vacondio F; Duranti A; Tontini A; Sanchini S; Sciolino NR; Spradley JM; Hohmann AG; Calignano A; Mor M; Tarzia G; Piomelli D
    Nat Neurosci; 2010 Oct; 13(10):1265-70. PubMed ID: 20852626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of Fatty Acid Amide Hydrolase Improves Depressive-Like Behaviors Independent of Its Peripheral Antinociceptive Effects in a Rat Model of Neuropathic Pain.
    Jiang HX; Ke BW; Liu J; Ma G; Hai KR; Gong DY; Yang Z; Zhou C
    Anesth Analg; 2019 Aug; 129(2):587-597. PubMed ID: 29863609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain permeant and impermeant inhibitors of fatty-acid amide hydrolase suppress the development and maintenance of paclitaxel-induced neuropathic pain without producing tolerance or physical dependence in vivo and synergize with paclitaxel to reduce tumor cell line viability in vitro.
    Slivicki RA; Xu Z; Mali SS; Hohmann AG
    Pharmacol Res; 2019 Apr; 142():267-282. PubMed ID: 30739035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Attenuation of cystitis and pain sensation in mice lacking fatty acid amide hydrolase.
    Wang ZY; Wang P; Hillard CJ; Bjorling DE
    J Mol Neurosci; 2015 Apr; 55(4):968-76. PubMed ID: 25374388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Normal aging in rats and pathological aging in human Alzheimer's disease decrease FAAH activity: modulation by cannabinoid agonists.
    Pascual AC; Martín-Moreno AM; Giusto NM; de Ceballos ML; Pasquaré SJ
    Exp Gerontol; 2014 Dec; 60():92-9. PubMed ID: 25456842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-acylethanolamine-hydrolyzing acid amidase and fatty acid amide hydrolase inhibition differentially affect N-acylethanolamine levels and macrophage activation.
    Alhouayek M; Bottemanne P; Makriyannis A; Muccioli GG
    Biochim Biophys Acta Mol Cell Biol Lipids; 2017 May; 1862(5):474-484. PubMed ID: 28065729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Piperazinyl carbamate fatty acid amide hydrolase inhibitors and transient receptor potential channel modulators as "dual-target" analgesics.
    Maione S; Costa B; Piscitelli F; Morera E; De Chiaro M; Comelli F; Boccella S; Guida F; Verde R; Ortar G; Di Marzo V
    Pharmacol Res; 2013 Oct; 76():98-105. PubMed ID: 23911581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of effect of chronic pre-treatment with the FAAH inhibitor URB597 on inflammatory pain behaviour: evidence for plastic changes in the endocannabinoid system.
    Okine BN; Norris LM; Woodhams S; Burston J; Patel A; Alexander SP; Barrett DA; Kendall DA; Bennett AJ; Chapman V
    Br J Pharmacol; 2012 Oct; 167(3):627-40. PubMed ID: 22595021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fatty acid amide hydrolase inhibitors--progress and potential.
    Khanna IK; Alexander CW
    CNS Neurol Disord Drug Targets; 2011 Aug; 10(5):545-58. PubMed ID: 21631410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of the peripheral FAAH inhibitor, URB937, in animal models of acute and chronic migraine.
    Greco R; Demartini C; Zanaboni A; Casini I; De Icco R; Reggiani A; Misto A; Piomelli D; Tassorelli C
    Neurobiol Dis; 2021 Jan; 147():105157. PubMed ID: 33129939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fatty acid amide hydrolase: biochemistry, pharmacology, and therapeutic possibilities for an enzyme hydrolyzing anandamide, 2-arachidonoylglycerol, palmitoylethanolamide, and oleamide.
    Fowler CJ; Jonsson KO; Tiger G
    Biochem Pharmacol; 2001 Sep; 62(5):517-26. PubMed ID: 11585048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The novel reversible fatty acid amide hydrolase inhibitor ST4070 increases endocannabinoid brain levels and counteracts neuropathic pain in different animal models.
    Caprioli A; Coccurello R; Rapino C; Di Serio S; Di Tommaso M; Vertechy M; Vacca V; Battista N; Pavone F; Maccarrone M; Borsini F
    J Pharmacol Exp Ther; 2012 Jul; 342(1):188-95. PubMed ID: 22514334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modifications of the ethanolamine head in N-palmitoylethanolamine: synthesis and evaluation of new agents interfering with the metabolism of anandamide.
    Vandevoorde S; Jonsson KO; Fowler CJ; Lambert DM
    J Med Chem; 2003 Apr; 46(8):1440-8. PubMed ID: 12672243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of cannabinoids and cannabinoid-enriched Cannabis extracts on TRP channels and endocannabinoid metabolic enzymes.
    De Petrocellis L; Ligresti A; Moriello AS; Allarà M; Bisogno T; Petrosino S; Stott CG; Di Marzo V
    Br J Pharmacol; 2011 Aug; 163(7):1479-94. PubMed ID: 21175579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of fatty acid amide hydrolase (FAAH) inhibitors on working memory in rats.
    Panlilio LV; Thorndike EB; Nikas SP; Alapafuja SO; Bandiera T; Cravatt BF; Makriyannis A; Piomelli D; Goldberg SR; Justinova Z
    Psychopharmacology (Berl); 2016 May; 233(10):1879-88. PubMed ID: 26558620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.